Invesco Mutual Fund
Sectoral / Thematic · Direct · Growth
NAV as of 30 Oct 2026 · Source: AMFI
Invesco India Pharma and Healthcare Fund is a Sectoral / Thematic fund from Invesco Mutual Fund, with NAVs going back to September 2026. This page covers its direct plan, growth option. It manages ₹468 crore. Its expense ratio is 3.30% a year.
AMFI's riskometer rates it Very High.
Annualised (CAGR) for periods over a year, calculated from AMFI NAVs up to 30 Oct 2026. Past performance does not guarantee future returns. How we calculate returns
Since launch (10 Sept 2026)
-23.45%
Measured from this fund's own daily NAVs over the last three years.
Daily NAV since 10 Sept 2026.
These come from the fund's monthly factsheet and Scheme Information Document (SID). We don't show them yet, because we can't keep them accurate. Check them on Invesco Mutual Fund's website before you invest.
No similar active funds found.
Invesco India Pharma and Healthcare Fund - Direct Plan - Growth
Research-only · No transactions